| Product Code: ETC6186395 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australia`s import trend for non-opioid pain patches witnessed a growth rate of 4.2% from 2023 to 2024, with a compound annual growth rate (CAGR) of 8.93% for 2020-2024. This uptrend can be attributed to a sustained demand shift towards non-opioid pain management solutions, indicating a stable market for such products during the period.
The non-opioid pain patch market in Australia is expanding due to increased demand for alternative pain relief methods. Patches containing lidocaine, capsaicin, and NSAIDs are gaining popularity due to their convenience and reduced risk of addiction.
The non-opioid pain patch market in Australia is growing due to increasing demand for drug-free pain management solutions. Rising adoption of lidocaine, capsaicin, and diclofenac-based patches, growing awareness about opioid addiction risks, and increasing availability of over-the-counter pain relief products are driving market growth.
The non-opioid pain patch market in Australia faces challenges from high production costs and limited patient access due to high retail prices. Regulatory requirements for product safety and efficacy increase operational complexity. Limited awareness among healthcare professionals and patients about the benefits of non-opioid pain relief further reduces market demand. Competition from alternative pain relief methods such as oral medications and physical therapies restricts market growth.
The non-opioid pain patch market in Australia is growing due to increasing awareness about opioid addiction and the demand for safer pain management solutions. Non-opioid patches, including lidocaine, capsaicin, and diclofenac-based patches, are gaining popularity for localized pain relief. Investment opportunities lie in developing long-acting formulations, improving skin adhesion technology, and expanding partnerships with healthcare providers. Growth in chronic pain cases and increased regulatory focus on reducing opioid dependence are driving market demand.
The TGA regulates the approval and sale of non-opioid pain patches, ensuring their safety and efficacy. The PBS subsidizes some non-opioid pain patches to improve patient access. The government funds research into alternative pain management therapies through the NHMRC. Educational campaigns aim to reduce opioid dependency and promote the use of non-opioid options for chronic pain management.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Non-opioid Pain Patch Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Non-opioid Pain Patch Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Non-opioid Pain Patch Market - Industry Life Cycle |
3.4 Australia Non-opioid Pain Patch Market - Porter's Five Forces |
3.5 Australia Non-opioid Pain Patch Market Revenues & Volume Share, By Non-opioid Pain Patch Type, 2021 & 2031F |
3.6 Australia Non-opioid Pain Patch Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Non-opioid Pain Patch Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the potential risks of opioid pain medications |
4.2.2 Growing demand for non-invasive pain management solutions |
4.2.3 Rising prevalence of chronic pain conditions in Australia |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of non-opioid pain patches |
4.3.2 Limited availability and accessibility of non-opioid pain patches in the market |
4.3.3 Competition from alternative pain management therapies |
5 Australia Non-opioid Pain Patch Market Trends |
6 Australia Non-opioid Pain Patch Market, By Types |
6.1 Australia Non-opioid Pain Patch Market, By Non-opioid Pain Patch Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Non-opioid Pain Patch Market Revenues & Volume, By Non-opioid Pain Patch Type, 2021- 2031F |
6.1.3 Australia Non-opioid Pain Patch Market Revenues & Volume, By Lidocaine Patches, 2021- 2031F |
6.1.4 Australia Non-opioid Pain Patch Market Revenues & Volume, By Diclofenac Patches, 2021- 2031F |
6.1.5 Australia Non-opioid Pain Patch Market Revenues & Volume, By Methyl Salicylate Patches, 2021- 2031F |
6.1.6 Australia Non-opioid Pain Patch Market Revenues & Volume, By Capsaicin Patches, 2021- 2031F |
6.1.7 Australia Non-opioid Pain Patch Market Revenues & Volume, By Ketoprofen Patches, 2021- 2031F |
6.1.8 Australia Non-opioid Pain Patch Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Non-opioid Pain Patch Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Australia Non-opioid Pain Patch Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 Australia Non-opioid Pain Patch Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2.4 Australia Non-opioid Pain Patch Market Revenues & Volume, By Independent Pharmacies & Drug Stores, 2021- 2031F |
7 Australia Non-opioid Pain Patch Market Import-Export Trade Statistics |
7.1 Australia Non-opioid Pain Patch Market Export to Major Countries |
7.2 Australia Non-opioid Pain Patch Market Imports from Major Countries |
8 Australia Non-opioid Pain Patch Market Key Performance Indicators |
8.1 Number of clinical trials and studies supporting the efficacy of non-opioid pain patches |
8.2 Patient satisfaction and feedback on the use of non-opioid pain patches |
8.3 Adoption rate of non-opioid pain patches by healthcare providers |
8.4 Average time taken for regulatory approval of new non-opioid pain patch products |
8.5 Number of partnerships and collaborations between pharmaceutical companies for the development and distribution of non-opioid pain patches |
9 Australia Non-opioid Pain Patch Market - Opportunity Assessment |
9.1 Australia Non-opioid Pain Patch Market Opportunity Assessment, By Non-opioid Pain Patch Type, 2021 & 2031F |
9.2 Australia Non-opioid Pain Patch Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Non-opioid Pain Patch Market - Competitive Landscape |
10.1 Australia Non-opioid Pain Patch Market Revenue Share, By Companies, 2024 |
10.2 Australia Non-opioid Pain Patch Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |